172 related articles for article (PubMed ID: 11048371)
41. Identifying men diagnosed with clinically localized prostate cancer who are at high risk for death from prostate cancer.
D'Amico AV; Hui-Chen M; Renshaw AA; Sussman B; Roehl KA; Catalona WJ
J Urol; 2006 Dec; 176(6 Pt 2):S11-5. PubMed ID: 17084157
[TBL] [Abstract][Full Text] [Related]
42. Comparison of digital rectal examination and prostate specific antigen in early detection of prostate cancer.
Galić J; Karner I; Cenan L; Tucak A; Hegedus I; Pasini J; Bilandzija-Peranović M; Mihaljević S
Coll Antropol; 2003; 27 Suppl 1():61-6. PubMed ID: 12955893
[TBL] [Abstract][Full Text] [Related]
43. Low prostate specific antigen levels and normal digital rectal examination--a report on a follow up cohort in general practice.
Brett T
Aust Fam Physician; 2005 Apr; 34(4):301-2. PubMed ID: 15861761
[No Abstract] [Full Text] [Related]
44. Making sense of prostate specific antigen: improving its predictive value in patients undergoing prostate biopsy.
Nam RK; Toi A; Trachtenberg J; Klotz LH; Jewett MA; Emami M; Sugar L; Sweet J; Pond GR; Narod SA
J Urol; 2006 Feb; 175(2):489-94. PubMed ID: 16406978
[TBL] [Abstract][Full Text] [Related]
45. [Prostate cancer].
Uchida K; Akaza H
Gan To Kagaku Ryoho; 2001 Oct; 28(10):1469-74. PubMed ID: 11681260
[TBL] [Abstract][Full Text] [Related]
46. Re: The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years?
Rosser CJ; Parker A
J Urol; 2005 Sep; 174(3):1154-5; author reply 1155-6. PubMed ID: 16094093
[No Abstract] [Full Text] [Related]
47. The impact of obesity on the diagnosis of prostate cancer using a modern extended biopsy scheme.
Pruthi RS; Swords K; Schultz H; Carson CC; Wallen EM
J Urol; 2009 Feb; 181(2):574-7; discussion 578. PubMed ID: 19084847
[TBL] [Abstract][Full Text] [Related]
48. Predictors of subsequent prostate cancer in men with a prostate specific antigen of 2.6 to 4.0 ng/ml and an initially negative biopsy.
Eggener SE; Roehl KA; Catalona WJ
J Urol; 2005 Aug; 174(2):500-4. PubMed ID: 16006880
[TBL] [Abstract][Full Text] [Related]
49. Prostate cancer detection in men with prostate specific antigen 4 to 10 ng/ml using a combined approach of contrast enhanced color Doppler targeted and systematic biopsy.
Pelzer A; Bektic J; Berger AP; Pallwein L; Halpern EJ; Horninger W; Bartsch G; Frauscher F
J Urol; 2005 Jun; 173(6):1926-9. PubMed ID: 15879783
[TBL] [Abstract][Full Text] [Related]
50. An elevated PSA, which normalizes, does not exclude the presence of prostate cancer.
Boddy JL; Pike DJ; Al-Hayek S; Shaida N; Malone PR
Prostate Cancer Prostatic Dis; 2005; 8(4):349-52. PubMed ID: 16010283
[TBL] [Abstract][Full Text] [Related]
51. Guidelines on the management of prostate cancer. A document for local expert groups in the United Kingdom preparing prostate management policy documents.
;
BJU Int; 1999 Dec; 84(9):987-1014. PubMed ID: 10571625
[No Abstract] [Full Text] [Related]
52. High result in prostate specific antigen test.
Mokete M; Palmer AR; O'Flynn KJ
BMJ; 2003 Aug; 327(7411):379. PubMed ID: 12919991
[No Abstract] [Full Text] [Related]
53. Survival benefit confirmed for prostate cancers diagnosed by PSA testing.
Lamb DS; Delahunt B; Denham J; Slaney D
N Z Med J; 2009 Jul; 122(1299):67-70. PubMed ID: 19684649
[No Abstract] [Full Text] [Related]
54. [Problems of prostate cancer in elderly patients].
Kato H; Nishizawa O
Nihon Rinsho; 2002 Dec; 60 Suppl 11():304-8. PubMed ID: 12599590
[No Abstract] [Full Text] [Related]
55. Prostate cancer: the epidemiologic perspective.
Levy I
Can J Oncol; 1994 Nov; 4 Suppl 1():4-7. PubMed ID: 8853479
[No Abstract] [Full Text] [Related]
56. Prostate-specific antigen best practice policy--part I: early detection and diagnosis of prostate cancer.
Carroll P; Coley C; McLeod D; Schellhammer P; Sweat G; Wasson J; Zietman A; Thompson I
Urology; 2001 Feb; 57(2):217-24. PubMed ID: 11182324
[No Abstract] [Full Text] [Related]
57. Prostate cancer screening rates remain stable despite recommendations against testing men with limited life expectancy.
Barton MK
CA Cancer J Clin; 2014; 64(4):221-2. PubMed ID: 24890093
[No Abstract] [Full Text] [Related]
58. Screening for prostate cancer.
Hensel WA
N Engl J Med; 1996 Mar; 334(10):667; author reply 667-8. PubMed ID: 8592543
[No Abstract] [Full Text] [Related]
59. Facing up to prostate cancer.
Ficorelli CT; Weeks B
Nursing; 2006 May; 36(5):66-8. PubMed ID: 16670611
[No Abstract] [Full Text] [Related]
60. Diagnosis and treatment of patients with prostate cancer: the nurse's role.
Turner B
Nurs Stand; 2007 Jun 6-12; 21(39):48-56; quiz 58. PubMed ID: 17569378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
